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Abstract
Meier-Gorlin syndrome (ear, patella, short stature syndrome) is an autosomal recessive primordial
dwarfism syndrome characterised by absent/hypoplastic patellae and markedly small ears1-3. Both
pre and post-natal growth are impaired in this disorder and although microcephaly is often evident,
intellect is usually normal. We report here that this disorder shows marked locus heterogeneity and
we identify mutations in five separate genes: ORC1, ORC4, ORC6, CDT1 and CDC6. All encode
components of the pre-replication complex, implicating defects in replication licensing as the
cause of a genetic syndrome with distinct developmental abnormalities.
In the accompanying paper4 we identified mutations in ORC1 encoding a subunit of the
origin recognition complex (ORC) in five patients with microcephalic primordial dwarfism.
The ORC multiprotein complex is loaded onto chromatin at DNA origins prior to S phase to
license replication. In conjunction with additional components CDT1, CDC6 and MCM
helicase proteins, it then forms the pre-replication complex (described in Fig. 1). Cellular
studies established that ORC1 patients had partial loss-of-function defects in replication
licensing4. An orc1 zebrafish model recapitulated the dwarfism phenotype as did
morpholino depletion of another pre-replication complex component, mcm5. This led us to
hypothesise that further pre-replication complex genes might cause primordial dwarfism,
however mutations in other ORC subunits were not found.
In this study, the profound growth retardation and microcephaly in a patient with a complex
lethal developmental syndrome led us to screen for ORC1 mutations. We found that he and
his brother (P1, P2, Table 1 and Supplementary Table 1) were compound heterozygote for
mutations in ORC1 (p.R105Q and p.V667fsX24). The combination of truncating and
missense mutations was in contrast to biallelic missense mutations seen in previous ORC1
cases, suggestive of greater loss-of-function and consistent with a more severe phenotype.
Unlike previous ORC1 cases, the proband (P1) had an extensive number of developmental
malformations including severe cortical dysplasia, congenital emphysema, absence of the
pancreatic tail and retroflexion of the knees; as well as micropenis, blepharophimosis and
cranial suture stenosis (Fig. 1). Notably, he also had significant microtia and absent patellae,
features classically associated with Meier-Gorlin syndrome (MIM 224690).
Consequently, we sequenced ORC1 in 33 patients with an established diagnosis of Meier-
Gorlin syndrome and identified two further cases with mutations in ORC1 (Table 1, Fig. 2).
Both patients from Families 2 and 3 were compound heterozygotes for the same ORC1
mutations: a splice acceptor site mutation in conjunction with the previously identified c.
314G>A that encodes the R105Q amino acid substitution4, again in contrast to the biallelic
missense mutations observed in the previous study. In Family 2, the c.314G>A mutation
was inherited on a haplotype shared with Family 1 (Supplementary Fig. 1), consistent with
common ancestry. However, the c.314G>A mutation in Family 3 and the two splice
acceptor site mutations in Family 2 and 3 appear to have arisen independently. Notably, P3
in Family 2 is the original patient described by Gorlin2, unequivocally establishing that
mutations in ORC1 cause Meier-Gorlin syndrome.
Sequencing the genes encoding other ORC subunits then identified pathogenic mutations in
two further subunits of the Origin Recognition Complex (ORC4, ORC6) in three patients
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with Meier-Gorlin syndrome (Table 1, Supplementary Table 1). Monozygotic twins P6 and
P7 were found to be homozygous for a missense mutation (c.521A>G, p.Y174C) in ORC4
(family also independently ascertained by M. Samuels and colleagues, ref. 5). The
substituted tyrosine was conserved throughout evolution as distant as S. cerevisiae and S.
pombe, and was located within Box VI of the AAA domain6 (Fig. 2), a domain that is
essential for ATP-dependent complex formation of ORC4 with other ORC subunits7,8. A
second patient, P5, is a compound heterozygote for this same Y174C substitution (present
on the ancestral haplotype shared with P6 and P7; Supplementary Fig. 1), in conjunction
with a four base-pair insertion mutation causing a translational frameshift and premature
protein termination.
In Family 6, three affected children were compound heterozygotes for mutations in ORC6.
Similar to P5, these patients inherited one loss-of-function mutation caused by a two base
pair deletion and a missense mutation resulting in the substitution (p.Y232S) of an amino
acid completely conserved from fungi to humans located at the C-terminus of the ORC6
protein (Fig. 2).
Given that mutations in genes encoding multiple components of the ORC complex cause
Meier-Gorlin syndrome, we next examined whether additional components of the pre-
replication complex could be similarly implicated. CDT1 and CDC6 are recruited to the pre-
replication complex following assembly of the full ORC complex on chromatin9. As the
region mutated in ORC6 is involved in CDT1 protein binding in S. cerevisiae10, we next
screened our Meier-Gorlin syndrome cohort for mutations in CDT1. Five families were
identified with compound heterozygous mutations in CDT1 (Table 1). In three of these
families, one of the mutations was c.1385G>A, causing the substitution R462Q in the C-
terminal winged helix domain of CDT1 (Fig. 2). This residue has been implicated in MCM
helicase complex binding through mutagenesis of the orthologous mouse residue
(p.R474Q)11, the same substitution as the human mutation we have identified here.
Finally, screening of CDC6 identified one Meier-Gorlin syndrome patient (P18)
homozygous for a missense mutation (c.968C>G), resulting in the substitution T323R. This
residue is absolutely conserved from fungi to humans (Fig. 2) and lies within the box VII
motif of the AAA domain (Fig. 2)6, an ATP binding domain that is essential for CDC6
function in DNA replication12.
We report here that mutations in multiple components of the pre-replication complex cause
Meier-Gorlin syndrome and despite finding marked genetic heterogeneity, identify an
underlying functional homogeneity in this disorder. The functional studies of ORC1 in the
accompanying manuscript4 establish that impairment of ORC1 function is associated with
extreme growth failure in humans. Here, our molecular genetic findings implicate the entire
pre-replication complex in primordial dwarfism syndromes, providing compelling genetic
evidence supporting the notion that impaired replication licensing causes growth failure.
Though most of the patients described in this paper have typical features of Meier-Gorlin
syndrome1-3, considerable phenotypic variation is seen from mutations in these genes,
particularly with the ORC1 cases reported here and in the accompanying paper4. Growth
parameters vary markedly (height ranges from −0.4 to −9.6 SD, and head circumference
from +1.7 to −9.8 SD), with cognition varying from normal to severe neurological
impairment associated with a severe cortical dysplasia. Thus, although microtia and small
patellae are the best predictors of mutations in the pre-replication complex, the disease
spectrum associated with these genes could extend from cases described as microcephalic
osteodysplastic primordial dwarfism I/III to those with nonsyndromic primordial dwarfism.
(Further discussion of clinical phenotypes, see Supplementary Note.)
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Impaired replication might be expected to affect growth of all tissues equally; therefore it is
noteworthy that specific tissues are disproportionately reduced in size, most readily apparent
in the ears and patellae. Most strikingly, significant congenital malformations are also
evident in several patients, affecting limb, genitourinary, lung and brain development. This
finding surprisingly links mutations in a chromatin bound protein complex regulating
replication with multiple congenital malformations. Such an association between chromatin
bound complexes involved in essential cellular functions and development is not
unprecedented. Notably in Cornelia de Lange syndrome (MIM 122470), mutations in the
cohesion complex also cause severe growth retardation though with very different
developmental consequences13.
The cellular mechanisms, by which preRC components cause the specific developmental
phenotypes reported here, are not immediately evident. It may be that proliferation of certain
cell types, such as chondrocytes in the ears and patellae are particularly sensitive to reduced
preRC function. Alternatively, these and the other developmental anomalies could result
from other cellular functions of the preRC components, as has been found for individual
ORC proteins 14.
Previous primordial dwarfism genes have DNA damage response and centrosome
functions15-17, while here we find mutations in genes involved in licensing of DNA
replication origins. All are critical components required for cell cycle progression.
Pathogenesis is therefore likely to be the result of impaired cellular proliferation, resulting in
reduced cell number and consequently global growth failure. While in this framework genes
regulating replication are rational candidates for primordial dwarfism, it is most surprising to
find specific congenital malformations occurring as the consequence of mutations in the pre-
replication complex. This suggests an unanticipated link between the regulation of
replication and development that warrants future investigation.
Methods
Research subjects
All patients in this study had previously been published as cases of Meier-Gorlin syndrome
or fulfilled diagnostic criteria for Meier-Gorlin syndrome (microtia, absent/small patellae
and short stature). Genomic DNA was isolated from peripheral blood of the affected
children and family members. No cytogenetic abnormalites were observed on routine
karyotyping of these Meier-Gorlin syndrome cases (n=10 patients). Furthermore, no
significant increase of either spontaneous, or radiation-induced chromosome breaks was
observed (2 cases versus 2 control patients, ≥ 100 metaphases assessed per patient; p≥ 0.7,
X2-test). Informed consent was obtained from all participating families and the studies were
approved by the Scottish Multicentre Research Ethics Committee (04:MRE00/19), Regional
Committee on Research Involving Human Subjects Nijmegen - Arnhem (0006-0119); or
University of Texas Southwestern Medical Center at Dallas (IRB #032008-066). Informed
consent was obtained for the publication of photographs.
Sequencing of candidate genes
Primers were designed using Exonprimer (Supplementary Table 2). Coding exons and exon-
intron boundaries of each gene were screened by bidirectional capillary sequencing on an
ABI 3730 gene sequencer. Primer sequences and PCR conditions are available upon request.
Sequence analysis and mutation detection performed using Mutation Surveyor v. 2.61
(Softgenetics LLC).
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Microsatellite Genotyping
Microsatellites were selected on the basis of heterozygosity and proximity to each gene.
Primer sequences for microsatellites were obtained from UniSTS. Amplicons were separated
by capillary electrophoresis on an ABI3730 Sequencer, and allele sizes obtained using
GeneMapper (Applied Biosystems).
Protein alignments
Reference sequences for all proteins were obtained from RefSeq and alignments performed
using ClustalW2. Protein domains were mapped using data obtained from Conserved
Domain Database (CCD).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. The pre-replication complex and Meier-Gorlin syndrome
(a) Genome replication is licensed by the binding of a number of specialised proteins to
origins of replication, which form the pre-replication complex9. The first step in complex
formation is the loading of the heterohexameric Origin Recognition Complex (comprising
ORC1-6 proteins), onto chromatin in an ATP dependent manner during M and G1 phases of
the cell cycle. Further proteins, including CDC6 and CDT1 are then recruited to the pre-
replicative complex, that then permit reiterative loading of the multimeric MCM helicase. At
the commencement of S-phase, replication is started by the MCM helicase unwinding DNA,
and the recruitment of additional replication proteins. The five proteins implicated in Meier-
Gorlin syndrome are highlighted in white text (ORC1, ORC4, ORC6, CDT1, CDC6). (b)
Patient 1 has a severe developmental malformation syndrome with marked microtia and
extreme retroflexion and dislocation of the knees (top row). His malformations included
lobar congenital emphysema (arrow head), and a severe cortical dysplasia of the brain.
Parasaggital T2 weighted MRI at age 1 month demonstrating severe pachygyria, most severe
frontally along with ventricular enlargement. (c) Two patients (P11, P9) with classical
Meier-Gorlin syndrome. b,c Informed consent to publish the photographs was obtained from
the subjects' parents.
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Figure 2. Pre-replication complex proteins mutated in Meier-Gorlin syndrome
Schematics for each protein depicting known protein domains with positions of mutations
shown by filled circles. Each filled circle represents one patient. Clustalw alignment of
protein residues surrounding substituted amino acids (positions of substituted resides
indicated by red boxes). WA, Walker A; WB Walker B, S1, Sensor 1; S2, Sensor 2; motifs.
BAH, Bromo Associated Homology domain; AAA, ATPase Associated with a wide range
of cellular Activites; WH, winged helix domain.
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er
ef
or
e 
th
e 
tra
ns
cr
ip
t i
s n
ot
 e
xp
ec
te
d 
to
u
n
de
rg
o 
no
ns
en
se
-m
ed
ic
at
ed
 m
RN
A
 d
ec
ay
. A
dd
iti
on
al
ly
, i
n 
CD
T1
 
th
e 
m
ut
at
io
n 
c.
35
1G
>C
 co
nf
er
s a
 n
on
-c
on
se
rv
at
iv
e a
m
in
o 
ac
id
 su
bs
tit
ut
io
n 
(p.
Q1
17
H)
, h
ow
ev
er 
the
 nu
cle
oti
de
 lie
s w
ith
in 
the
 ex
on
 2 
sp
lic
e d
on
or 
sit
e a
nd
 th
ere
for
e t
his
 m
uta
tio
n i
s e
xp
ec
ted
 to
 re
su
lt i
n a
n
in
fra
m
e 
de
le
tio
n 
of
 e
xo
n 
3 
fro
m
 th
e 
tra
ns
cr
ip
t a
nd
 re
su
lti
ng
 p
ro
te
in
. T
R,
 T
ur
ke
y;
 N
Z,
 N
ew
 Z
ea
la
nd
; F
R,
 F
ra
nc
e;
 S
A
, S
au
di
 A
ra
bi
a;
 S
D
, s
ta
nd
ar
d 
de
vi
at
io
n,
 O
FC
, o
cc
ip
ito
-fr
on
ta
l c
irc
um
fe
re
nc
e;
 N
A
, n
ot
 a
va
ila
bl
e;
 u
, u
nk
no
w
n.
Nat Genet. Author manuscript; available in PMC 2011 October 01.
